C Mini-pumps

  • Dirk GläserEmail author
  • Jürg Liniger
  • Daniel Peter
Part of the AAPS Advances in the Pharmaceutical Sciences Series book series (AAPS, volume 38)


Mini-pumps for bolus injection contribute to keep pace with the requirements for drug delivery devices driven by specific properties of protein therapeutics in combination with particular usability needs. Introductory Sect. 11.1 reflects on the growing requirements on drug delivery devices for biologics in connection with new indications and user groups. Section 11.2 discusses the boundary conditions, physical basics and technical requirements. Section 11.3 deals with the different types of pumps and their classification. In Sect. 11.4, the different drive concepts and their application areas are discussed and Sect. 11.5 looks at new trends and related requirements for mini-pumps. Finally, Sect. 11.6 makes considerations on USA and EU regulations applicable for those devices.


Drug delivery device Mini-pump Bolus injector Pen injector Patch injector Micro-dosing pump 


  1. 1.
    Elvin JG, Couston RG, van der Walle CF. Therapeutic antibodies: market considerations, disease targets and bioprocessing. Int J Pharm. 2013;440:83–98.CrossRefPubMedGoogle Scholar
  2. 2.
    Aggarwal SR. What’s fueling the biotech engine—2012 to 2013. Nat Biotechnol. 2014;32:32–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Shpilberg O, Jackisch C. Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase, 2013.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Poiseuille JLM. Recherches expérimentales sur le mouvement des liquides dans les tubes de très petits diamètres. CR Acad Sci. 1840;11:1041–8.Google Scholar
  5. 5.
    Reynolds O. An experimental investigation of the circumstances which determine whether the motion of water shall be direct or sinuous, and of the law of resistance in parallel channels. Philos Trans. 1883;174:935–82.CrossRefGoogle Scholar
  6. 6.
    Reynolds O. On the dynamical theory of incompressible viscous fluids and the determination of the criterion. Philos Trans Royal Soc London. A. 1895;186:123–64.CrossRefGoogle Scholar
  7. 7.
    Zarraga E et al. High shear rheology and anisotropy in concentrated solutions of monoclonal antibodies. J Pharm Sci. Aug 2013;102(8):2538–49.CrossRefPubMedGoogle Scholar
  8. 8.
    Rathore N et al. Pharmaceutics, preformulation and drug delivery - characterization of protein rheology and delivery forces for combination products, J Pharm Sci. Dec 2012;101(12).CrossRefPubMedGoogle Scholar
  9. 9.
    Allmendinger A, et al. Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions. Eur J Pharm Biopharm. 2014. Scholar
  10. 10.
    Dias C et al. Tolerability of high-volume subcutaneous injections of a viscous Placebo buffer: a randomized, crossover study in healthy subjects, AAPS PharmSciTech. Oct 2015;16(5).Google Scholar
  11. 11.
    Berteau C, et al. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance. Med Dev Evid Res. 2015;8:473–84.Google Scholar
  12. 12.
    COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices, 1993L0042—EN—11.10.2007— 005.001.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  1. 1.Device DevelopmentF. Hoffmann-La Roche LtdBaselSwitzerland

Personalised recommendations